Biotech stocks head south, led by Alexion
April 25, 2011 at 10:22 AM EDT
Alexion leads biotech stocks south as shares of the drug developer fall on a downgrade by Needham & Co.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.